Table 1.
Exosomal cargo | Donor cells | Recipient cells | Role/Mechanism | Ref. |
---|---|---|---|---|
miR-27a | Gastric cancer | Stroma fibroblasts | Tumorigenesis and metastasis/CSRP2 | (15) |
BMP | Gastric cancer | Pericytes | Metastasis/PI3K and MEK pathway | (16) |
TGF-β | Gastric cancer | MSCs | Metastasis/Smad | (17) |
TRIM3/ ZFAS1 | Gastric cancer | Gastric cancer | Growth and metastasis/EMT | (18, 19) |
circNRIP1 | Serum | Gastric cancer | metastasis/miR-149-5p-AKT-mTOR | (20) |
\ | Gastric cancer | PMCs | MMT/ERK pathway | (21) |
miR-21-5p | Gastric cancer | PMCs | MMT/TGF-β pathway | (22) |
miR-106a | Gastric cancer | PMCs | Apoptosis/SMAD7 | (23) |
Wnt3a | Gastric cancer | PMCs | Tumor invasion | (24) |
VEGF,TIMP-1,IL6,IL8,FGF | Gastric cancer | Endothelial cell | Angiogenesis | (25, 26) |
miR-130a | Gastric cancer | Endothelial cell | Angiogenesis/c-MYB | (27) |
miR-135b/155 | Gastric cancer | Endothelial cell | Angiogenesis/FOXO1/3 | (28, 29) |
MET | Gastric cancer | macrophage | Proinflammatory environment/ NF-κB /IL-1β | (30, 31) |
\ | Gastric cancer | PD1+TAMs | Immunosuppression/IL10 | (32) |
\ | Gastric cancer | MSCs | Inflammatory environment/ NF-κB | (33) |
miR-107 | Gastric cancer | MDSCs | Immunosuppression/DICER1,PTEN | (34) |
miR-451 | Gastric cancer | Th17 | Angiogenesis/mTOR | (35) |
HMGB1 | Gastric cancer | neutrophils | Migration/ NF-κB | (36) |
\ | Gastric cancer | CD8+Tcell | Immunosuppression/cytokine | (37) |
\ | CAF | Gastric cancer | Invasion/MMP2 | (38) |
\ | Gastric cancer | PMCs | Adhesion/fibronectin,laminin gamma10 | (39) |
CD44H,CD44v6 | Gastric cancer | Gastric cancer | Growth,angiogenesis | (40) |
Let-7 miRNA | AZ-P7a | Gastric cancer | ,Tumorigenesisi, PM | (41) |
TGF-β,Wnt3,HIFα,Src | Gastric cancer | Stromal cell | MMT | (42) |
miR-139 | CAF | Gastric cancer | Growth and metastasis/MMP11 | (43) |
ApoE | TAMs | Gastric cancer | Migration/PI3K-AKT | (44) |
IL6,IL8,ICAM1,GRO | Omentum | Gastric cancer | Progression/metastasis | (45–48) |
miR-544-5p | PLF | PMCs | MMT/PLZF | (49) |
\ | MA | PMCs/GC | Metastasis/ MMT, EMT | (50, 51) |